Antioxidant effects of calcium antagonists in rat brain homogenates

Biological and Pharmaceutical Bulletin

Volumn 23, Issue 6, 2000, Pages 766-769

  Yao, Kozo ^a   Ina, Yasuhiro ^a   Nagashima, Ken ^a   Ohmori, Kenji ^a   Ohno, Tetsuji ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Antioxidant effect; Calcium antagonist; Lipid peroxidation

Indexed keywords

AMLODIN; AMLODIPINE; BENIDIPINE; CALCIUM ANTAGONIST; DILTIAZEM; LIPID PEROXIDE; MEPIRODIPINE; NICARDIPINE; NIFEDIPINE; NILVADIPINE; NITRENDIPINE; VERAPAMIL;

ANTIOXIDANT ACTIVITY; ARTICLE; AUTOOXIDATION; BRAIN HOMOGENATE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; LIPID PEROXIDATION; MALE; NONHUMAN; RAT;

EID: 0033946879     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.23.766     Document Type: Article

References (23)

1. Sasaki S., Nakagawa M., Jpn. J. Clin. Med., 55, 2061-2066 (1997).
2. Resnic L. M., Ethnicity Dis., 8, 111-119 (1998).
3. Triggle D. J., Janis R. A., Annu. Rev. Pharmac. Toxicol., 27, 347-369 (1987).
4. Mak I. T., Weglicki W. B., Circ. Res., 66, 1449-1452 (1990).
5. Mason R. P., Trumbore M. W., Biochem. Pharmacol., 51, 653-660 (1996).
6. Rojstaczer N., Triggle D. J., Biochem. Pharmacol., 51, 141-150 (1996).
7. Sugawara H., Tobise K., Kikuchi K., Hypertens. Res., 19, 223-228 (1996).
8. Behl C., Int. J. Vitamin Nurt. Res., 69, 213-219 (1999).
9. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M., Nature (London), 380, 168-171 (1996).
10. Markesbery W. R., Carney J. M., Brain Pathol., 9, 133-146 (1999).
11. Stocks J., Gutteridge J. M. C., Sharp R. J., Dormandy T. L., Clin. Sci. Mol. Med., 47, 215-222 (1974).
12. Kubo K., Yoshitake I., Kumada Y., Shuto K., Nakamizo N., Arch. Int. Pharmacodyn., 272, 283-295 (1984).
13. Aruoma O. I., Smith C., Cecchini R., Evans P. J., Halliwell B., Biochem. Pharmacol., 42, 735-743 (1991).
14. Engineer F., Sridhar R., Biochem. Pharmacol., 38, 1279-1285 (1989).
15. Ondrias K., Misik V., Gergel D., Stasko A., Biochim. Biophys. Acta. 1003, 238-245 (1989).
16. Janero D. R., Burghardt B., Lopez R., Biochem. Pharmacol., 37, 4197-4203 (1988).
17. Rohak J., Duniec Z., Pharmacol. Res. Commun., 18, 1107-1117 (1986).
18. Mason R. P., Moisey D. M., Shajenko L., Mol. Pharmacol., 41, 315-321 (1992).
19. Nosaka C., Ishii A., Clin. Rep., 25, 3887-3893 (1991).
20. Kitakaze M., Karasawa A., Kobayasi H., Tanaka B. S., Kuzuya T., Hori M., Cardiovasc. Drug Rev., 17, 1-15 (1999).
21. Leys D., Pasquier F., Lancet, 353, 236 (1999).
22. Forette F., Seux M. L., Staessen J. A., Thijs L., Birkenhaeger W. H., Lancet, 352, 1347-1351 (1998).
23. SHEP Cooperative Research Group, JAMA, 265, 3255-3264 (1991).